SG50567A1 - Pharmaceutical preparations containing plasminogen activators - Google Patents

Pharmaceutical preparations containing plasminogen activators

Info

Publication number
SG50567A1
SG50567A1 SG1996005074A SG1996005074A SG50567A1 SG 50567 A1 SG50567 A1 SG 50567A1 SG 1996005074 A SG1996005074 A SG 1996005074A SG 1996005074 A SG1996005074 A SG 1996005074A SG 50567 A1 SG50567 A1 SG 50567A1
Authority
SG
Singapore
Prior art keywords
pct
pharmaceutical preparations
preparations containing
plasminogen activators
containing plasminogen
Prior art date
Application number
SG1996005074A
Other languages
English (en)
Inventor
Ulrich Kohnert
Stephan Fischer
Hans-Jorg Markl
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SG50567A1 publication Critical patent/SG50567A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996005074A 1994-02-21 1995-02-18 Pharmaceutical preparations containing plasminogen activators SG50567A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405426A DE4405426A1 (de) 1994-02-21 1994-02-21 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate

Publications (1)

Publication Number Publication Date
SG50567A1 true SG50567A1 (en) 1998-07-20

Family

ID=6510724

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005074A SG50567A1 (en) 1994-02-21 1995-02-18 Pharmaceutical preparations containing plasminogen activators

Country Status (26)

Country Link
US (1) US5747030A (es)
EP (1) EP0746334B1 (es)
JP (1) JP3868997B2 (es)
KR (1) KR100356934B1 (es)
CN (1) CN1170591C (es)
AT (1) ATE205091T1 (es)
AU (1) AU691881B2 (es)
BR (1) BR9506840A (es)
CA (1) CA2183755C (es)
CZ (1) CZ286682B6 (es)
DE (2) DE4405426A1 (es)
DK (1) DK0746334T3 (es)
ES (1) ES2162913T3 (es)
FI (1) FI117925B (es)
HU (1) HU219769B (es)
MX (1) MX9603515A (es)
NO (1) NO317726B1 (es)
NZ (1) NZ281607A (es)
PL (1) PL181257B1 (es)
PT (1) PT746334E (es)
RU (1) RU2155067C2 (es)
SG (1) SG50567A1 (es)
SK (1) SK282827B6 (es)
TW (1) TW337997B (es)
WO (1) WO1995022347A1 (es)
ZA (1) ZA951371B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
CN101584858A (zh) 2005-12-20 2009-11-25 布里斯托尔-迈尔斯斯奎布公司 稳定蛋白质制剂
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
AR095527A1 (es) 2013-03-15 2015-10-21 Biogen Idec Inc Formulaciones de polipéptido fc-factor ix
EA202092926A3 (ru) * 2014-03-24 2021-10-29 Биовератив Терапьютикс Инк. Лиофилизированные составы, содержащие фактор ix
US11666532B2 (en) * 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
US10980757B2 (en) 2018-09-06 2021-04-20 RTU Pharma SA Ready-to-use tranexamic acid intravenous solution
CN116033931A (zh) * 2020-08-10 2023-04-28 奇斯药制品公司 组织纤溶酶原激活剂制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro

Also Published As

Publication number Publication date
KR100356934B1 (ko) 2003-02-26
CN1141592A (zh) 1997-01-29
FI117925B (fi) 2007-04-30
CA2183755C (en) 2004-02-17
EP0746334B1 (de) 2001-09-05
CZ243196A3 (en) 1997-01-15
HU9602284D0 (en) 1996-10-28
NZ281607A (en) 1997-04-24
US5747030A (en) 1998-05-05
KR970701059A (ko) 1997-03-17
DE59509580D1 (de) 2001-10-11
FI963251L (fi) 1996-08-20
HUT74843A (en) 1997-02-28
ZA951371B (en) 1996-08-20
SK107996A3 (en) 1997-04-09
CZ286682B6 (en) 2000-06-14
ATE205091T1 (de) 2001-09-15
NO963460L (no) 1996-10-18
TW337997B (en) 1998-08-11
AU1758195A (en) 1995-09-04
FI963251A0 (fi) 1996-08-20
JPH09511495A (ja) 1997-11-18
CN1170591C (zh) 2004-10-13
SK282827B6 (sk) 2002-12-03
DK0746334T3 (da) 2001-12-27
MX9603515A (es) 1997-03-29
HU219769B (hu) 2001-07-30
NO317726B1 (no) 2004-12-13
PL315978A1 (en) 1996-12-23
NO963460D0 (no) 1996-08-20
RU2155067C2 (ru) 2000-08-27
EP0746334A1 (de) 1996-12-11
DE4405426A1 (de) 1995-08-24
CA2183755A1 (en) 1995-08-24
BR9506840A (pt) 1997-10-14
PT746334E (pt) 2002-02-28
AU691881B2 (en) 1998-05-28
WO1995022347A1 (de) 1995-08-24
ES2162913T3 (es) 2002-01-16
PL181257B1 (pl) 2001-06-29
JP3868997B2 (ja) 2007-01-17

Similar Documents

Publication Publication Date Title
SG50567A1 (en) Pharmaceutical preparations containing plasminogen activators
PL319833A1 (en) Compounds and composition for carrying active media
AU610636B2 (en) Stabilised human protein preparations
GR3022510T3 (en) Lyospheres comprising gonadotropin
AU6995794A (en) Aspb28 insulin crystals
DE69531457D1 (en) Sulfonamide
AU697761B2 (en) Decontaminating blood components with 8-methoxypsoralen
CA2131168A1 (en) Decontaminating blood components
MY103943A (en) Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical compositions containing it
AU586237B2 (en) Non dusty blends of meals or flours with active principles for use in fodder production
AU1446488A (en) 2-hydroxy-3-aminopropionic-n,n-diacetic acid and derivatives thereof, preparation thereof, and detergents containing same
AU1732288A (en) A process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
MY102929A (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
DK0688226T3 (da) Proteinpræparat til forebyggelse og terapi af periodontitis eller andre bakterielle patologier i mundhulen
SE9300105D0 (sv) Stable protein solution
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
NO20003888L (no) Anti-enzympreparater omfattende etylendiamindiravsyre
AU1870397A (en) Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
AU7037591A (en) Stabilization of t-pa pro
CA2086835A1 (en) Tissue plasminogen activator variants with decreased clearance
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
MX9704388A (es) Incremento de la concentracion de creatina y glicogeno en musculos.